Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts

Antiviral Research

Volumn 51, Issue 2, 2001, Pages 141-149

  Andersen, Jeanette Hammer ^a   Osbakk, Svein Are ^a   Vorland, Lars Harry ^a,b   Traavik, Terje ^b   Gutteberg, Tore Jarl ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Human cytomegalovirus (HCMV); Lactoferricin; Lactoferrin

Indexed keywords

CYCLOPEPTIDE; HEPARIN DERIVATIVE; IRON; LACTOFERRICIN B; LACTOFERRIN;

AMINO TERMINAL SEQUENCE; ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG ACTIVITY; DRUG EFFECT; DRUG EXPOSURE; FIBROBLAST; HOST CELL; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROGENY; SPECIES DIFFERENCE; VIROGENESIS; VIRUS CONCENTRATION; VIRUS INHIBITION;

FUNGI; HUMAN HERPESVIRUS 5; MAMMALIA;

EID: 0034960102     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(01)00146-2     Document Type: Article

References (40)

1. Structure of human lactoferrin: Crystallographic structure analysis and refinement at 2.8 Å resolution
2. Three-dimensional structure of lactoferrin in various functional states
3. Identification of the bactericidal domain of lactoferrin
4. Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin
5. Cytomegalovirus
6. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
7. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate
8. Structural organization of the mouse lactoferrin gene
9. Studies of the N-terminal half of human lactoferrin produced from the cloned cDNA demonstrate that interlobe interactions modulate iron release
10. Structure of the recombinant N-terminal lobe of human lactoferrin at 2.0 Å resolution
11. BK virus in cell culture: Infectivity quantitation and sequential expression of antigens detected by immunoperoxidase staining
12. Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea
13. The latency of serum acute phase proteins in meningococcal septicemia, with special emphasis on lactoferrin
14. Lactoferrin as an indicator of septicemia and endotoxemia in pigs
15. Antiviral effects of plasma and milk proteins: Lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro
16. Inhibition with lactoferrin of in vitro infection with human herpes virus
17. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin
18. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes
19. Protective effect of lactoferricin against Toxoplasma gondii infection in mice
20. Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG
21. A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope
22. Characterization of the goat lactoferrin cDNA: Assignment of the relevant locus to bovine U12 synteny group
23. Nucleotide and primary amino acid sequence of porcine lactoferrin
24. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin
25. Metal complexes of bovine lactoferrin inhibit in vitro replication of herpes simplex virus type 1 and 2
26. An iron-binding protein common to many external secretions
27. Human lactotransferrin: Amino acid sequence and structural comparisons with other transferrins
28. Cytomegalovirus and their replication
29. A steroid hormone response unit in the late leader of the noncoding control region of the human polyomavirus BK confers enhanced host cell permissivity
30. Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate
31. Molecular cloning and sequence analysis of bovine lactotransferrin
32. Isolation and characterization of sheep lactoferrin, an inhibitor of platelet aggregation and comparison with human lactoferrin
33. Nuclear targeting of the tegument protein pp65 (UL83) of human cytomegalovirus: An unusual bipartite nuclear localization signal functions with other portions of the protein to mediate its efficient nuclear transport
34. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin
35. Lactoferrin. Antiviral activity of lactoferrin
36. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin
37. Giardicidal activity of lactoferrin and N-terminal peptides
38. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin
39. Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice
40. Heparin-binding properties of lactoferrin and lysozyme